SCHEMBL10043334

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL10043145	1.00	OPRL1 (0.37)	OPRL1DGAT1GRM2CYP2C9
	SCHEMBL10043154	0.90	OPRL1 (0.39)	OPRL1
	SCHEMBL10043156	0.90	CYP2C9 (0.42)	OPRL1CYP2C9
	SCHEMBL10043084	0.89	ESR2 (0.37)	OPRL1DGAT1
	SCHEMBL16546503	0.89	ESR2 (0.37)	OPRL1DGAT1
	SCHEMBL12975882	0.89	ESR2 (0.37)	OPRL1DGAT1
	SCHEMBL3437354	0.89	TRPV3 (0.32)	—
	SCHEMBL8015649	0.89	TRPV3 (0.32)	—
	SCHEMBL18512507	0.89	TRPV3 (0.32)	—
	SCHEMBL8736434	0.89	TRPV3 (0.32)	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.